Pathology of Tumor Viruse
Pathology of Tumor Viruse
The discovery of multiple oncogenic viruses during the 20th century has revolutionized the health sciences, laying the foundations for a deeper biopathological understanding of multiple cancer types and the development of preventive and therapeutic strategies. The development of vaccines for human papillomavirus is a well-known example that currently delivers worldwide health benefits. In the field of veterinary sciences, bovine papillomavirus and other papillomaviruses remain an important health problem, calling for additional research efforts. Despite progression in recent decades, other tumor viruses like the enzootic nasal tumor virus, enzootic bovine leukosis, the rabbit myxoma virus, Marek's disease virus or feline leukemia virus are also associated with significant morbidity and mortality in domestic and wild-animals.
Further efforts are needed to improve our knowledge of many tumor viruses that affect domestic and wild animals, and to support the veterinary community in its goal of controlling those agents and their related lesions.
Therefore, we cordially ask researchers working on this field all over the world to contribute to the present Research. Topic which will bring together original research articles, review articles and perspectives on all animal tumor viruses, aiming to support research in the field of tumor viruses.
The scope of this Research Topic includes, but is not limited:
• Viral epidemiology
• Diagnostic and monitoring methods
• Virus-host interactions including viral pathogenesis and pathology
• Disease prevention including vaccination
• Disease therapy and management
How we work:
- After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
- A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
- Author proof is generated within 7 working days after the acceptance decision.
Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.
Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.
Media Contact:
Stella M
Journal Manager
Immunome Research
Email: immunome@immunologyjournals.org
https://www.longdom.org/immunome-research.html